Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 1, 2034

Conditions
MultimorbidityHealthy
Interventions
DRUG

Fisetin

Subjects will receive fisetin corresponding to 20 mg/kg/day for two consecutive days.

DRUG

Placebo

Subjects will receive a corresponding number of placebo capsules for two consecutive days.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

collaborator

Mayo Clinic

OTHER

lead

Ove Andersen

OTHER

NCT06431932 - Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity | Biotech Hunter | Biotech Hunter